The Proportion of Activated B-cell Like Subtype Among De Novo Diffuse Large B-cell Lymphoma Increases with Age

Overview

Journal Haematologica

Specialty Hematology

Date 2011 Aug 24

PMID 21859735

Citations 38

Authors

Sylvain Mareschal

Helene Lanic

Philippe Ruminy

Christian Bastard

Herve Tilly

Fabrice Jardin

Affiliations

Soon will be listed here.

Citing Articles

Diffuse Large B-Cell Lymphoma in the Older and Frail Patient.

Ayers E, Smith S Cancers (Basel). 2025; 17(5).

PMID: 40075732 PMC: 11899176. DOI: 10.3390/cancers17050885.

Diffuse large B cell lymphoma (DLBCL): epidemiology, pathophysiology, risk stratification, advancement in diagnostic approaches and prospects: narrative review.

Berhan A, Almaw A, Damtie S, Solomon Y Discov Oncol. 2025; 16(1):184.

PMID: 39954204 PMC: 11829893. DOI: 10.1007/s12672-025-01958-w.

Racial and ethnic disparities in outcomes of diffuse large B cell lymphoma in adolescent and young adults: a SEER database analysis.

Aqeel S, Faisal M, Akhtar O, Attwood K, George A, Advani P Ann Hematol. 2024; 103(12):5539-5547.

PMID: 39495284 DOI: 10.1007/s00277-024-06075-2.

[Chinese expert consensus on the diagnosis and management of elderly patients with diffuse large B-cell lymphoma (2024)].

Zhonghua Xue Ye Xue Za Zhi. 2024; 45(4):322-329.

PMID: 38951058 PMC: 11168000. DOI: 10.3760/cma.j.cn121090-20231228-00343.

Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence.

Lage L, De Vita R, Alves L, Jacomassi M, Culler H, Reichert C Cancers (Basel). 2024; 16(8).

PMID: 38672542 PMC: 11048621. DOI: 10.3390/cancers16081459.

References

Hofscheier A, Ponciano A, Bonzheim I, Adam P, Lome-Maldonado C, Vela T . Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population. Mod Pathol. 2011; 24(8):1046-54. DOI: 10.1038/modpathol.2011.62. View

Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile J, Castaigne S . Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2011; 12(5):460-8. DOI: 10.1016/S1470-2045(11)70069-9. View

Ruminy P, Etancelin P, Couronne L, Parmentier F, Rainville V, Mareschal S . The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma. Leukemia. 2011; 25(4):681-8. DOI: 10.1038/leu.2010.302. View

Lenz G, Wright G, Dave S, Xiao W, Powell J, Zhao H . Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008; 359(22):2313-23. PMC: 9103713. DOI: 10.1056/NEJMoa0802885. View

Lenz G, Wright G, Emre N, Kohlhammer H, Dave S, Davis R . Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A. 2008; 105(36):13520-5. PMC: 2533222. DOI: 10.1073/pnas.0804295105. View

Lanic H, Mareschal S, Mechken F, Picquenot J, Cornic M, Maingonnat C . Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma. Leuk Lymphoma. 2011; 53(1):34-42. DOI: 10.3109/10428194.2011.600482. View

Jardin F, Sahota S, Ruminy P, Parmentier F, Picquenot J, Rainville V . Novel Ig V gene features of t(14;18) and t(3;14) de novo diffuse large B-cell lymphoma displaying germinal center-B cell like and non-germinal center-B cell like markers. Leukemia. 2006; 20(11):2070-4. DOI: 10.1038/sj.leu.2404370. View

Rosenwald A, Wright G, Chan W, Connors J, Campo E, Fisher R . The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346(25):1937-47. DOI: 10.1056/NEJMoa012914. View

Oschlies I, Klapper W, Zimmermann M, Krams M, Wacker H, Burkhardt B . Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood. 2006; 107(10):4047-52. DOI: 10.1182/blood-2005-10-4213. View

10.

Kobayashi Y, Miura K, Hojo A, Hatta Y, Tanaka T, Kurita D . Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2011; 137(7):1079-84. DOI: 10.1007/s00432-010-0973-x. View

11.

Gibson K, Wu Y, Barnett Y, Duggan O, Vaughan R, Kondeatis E . B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell. 2008; 8(1):18-25. PMC: 2667647. DOI: 10.1111/j.1474-9726.2008.00443.x. View

12.

Wang X, Stollar B . Immunoglobulin VH gene expression in human aging. Clin Immunol. 1999; 93(2):132-42. DOI: 10.1006/clim.1999.4781. View